Total amount raised
$58.7M
Latest funding date
2025-05-15
Location
NeuroFlow has raised funding across multiple rounds backed by investors including SEMCAP Health, Magellan Health, Builders VC, Concord Health Partners, and the National Science Foundation.
Keep reading to explore NeuroFlow's fundraising journey, from its early seed rounds to its most recent grant in 2025.
What Is NeuroFlow?
NeuroFlow is a Philadelphia-based behavioral health integration technology company. Its HIPAA-compliant digital health platform optimizes the way behavioral healthcare is delivered, tracked, and assessed, enabling healthcare organizations to integrate mental and behavioral health into primary and specialty care settings.
How Much Funding Has NeuroFlow Raised?
- Seed Round #1
- Amount Raised: USD 1,250,000
- Date: October 2017
- Lead Investors: Ben Franklin Technology Partners / Safeguard Scientifics / Independence Health Group digital health fund
- Participants: GAP International (via venture capital arm)
- Seed Round #2
- Amount Raised: USD 1,200,000
- Date: September 2018
- Lead Investors: NJ JumpStart
- Participants: Independence Blue Cross, Chestnut Street Ventures, Ben Franklin Technology Partners
- Grant (STTR Phase I)
- Amount Raised: USD 225,000
- Date: October 2018
- Lead Investors: U.S. Department of Defense / Veterans Hospital
- Series A
- Amount Raised: USD 7,500,000
- Date: December 2019
- Lead Investors: Builders VC
- Participants: Dreamit Ventures, Spring Point Partners, Red & Blue Ventures, AWT Private Investments
- Grant (NSF SBIR Phase II)
- Amount Raised: USD 750,000
- Date: April 2020
- Lead Investors: National Science Foundation
- Series B
- Amount Raised: USD 20,000,000
- Date: January 2021
- Lead Investors: Magellan Health Services
- Series C
- Amount Raised: USD 25,000,000
- Date: October 2022
- Lead Investors: SEMCAP Health
- Participants: Novant Health
- Venture Round
- Amount Raised: Undisclosed
- Date: September 2023
- Lead Investors: Concord Health Partners
- Grant
- Amount Raised: USD 2,798,014
- Date: May 2025
- Lead Investors: Not publicly disclosed
Total Amount Raised: At least $58.7M based on disclosed funding (including $55.9M across disclosed rounds plus the 2023 venture round at undisclosed amount).
Key Investors
- SEMCAP Health
- Details: SEMCAP Health is a growth impact equity investor. It led NeuroFlow's $25M Series C in October 2022, with Managing Director Mark Miller joining NeuroFlow's Board of Directors as part of the transaction.
- Magellan Health Services
- Details: Magellan Health (NASDAQ: MGLN) is a managed healthcare organization focused on behavioral health. It led NeuroFlow's $20M Series B in January 2021.
- Builders VC
- Details: Builders VC is a San Francisco-based early-stage venture capital firm. It led NeuroFlow's $7.5M Series A in December 2019.
- Concord Health Partners
- Details: Concord Health Partners is a healthcare-focused investment firm. It invested in NeuroFlow in September 2023 out of its Concord Innovation Fund II, which closed with $150M in commitments. The investment amount was not disclosed.
- National Science Foundation
- Details: The NSF awarded NeuroFlow a $750,000 SBIR Phase II grant in April 2020 to advance artificial intelligence and natural language processing capabilities in its behavioral health platform.
What's Next for NeuroFlow?
NeuroFlow is positioned to continue expanding its behavioral health integration platform across health systems, payers, and government partnerships. With a growing portfolio of clinical evidence and enterprise contracts, the company aims to deepen its presence in value-based care and demonstrate measurable outcomes in behavioral health.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data. Sign up for free today.
